Navigation Links
AutismOnline.org Partners With Leading Health Communications Firm for Support
Date:3/25/2008

Danya Relaunches Site With Expanded Resources for Individuals With Autism and Their Families

SILVER SPRING, Md., March 25 /PRNewswire-USNewswire/ -- Danya International, Inc. (Danya), a health and education communications, research, and technology firm, has acquired AutismOnline.org, a trusted resource for individuals with autism and their families.

AutismOnline links parents and caregivers to support, research, and products in a variety of languages concerning the complex developmental disorder. Approximately 1 in 150 children has a diagnosis of an autism spectrum disorder, which affects the person's ability to communicate and interact with others.

"When a parent has a newly diagnosed child, sifting through hundreds of Web sites can be confusing and time consuming," said Jeff Hoffman, Ph.D., President and CEO of Danya. "It is our hope that in relaunching AutismOnline and continually updating its resources parents will be better served and, in return, will be better able to serve their loved ones with autism."

AutismOnline.org was founded by Ayda Sanver, a parent of a child with autism, and the current Director of the Community Development for CSAAC, a nonprofit agency serving children and adults with autism in Maryland. She approached Danya in 2007 to take over AutismOnline when the site's activity grew beyond what the family and its nonprofit organization could manage.

"We approached Danya because we knew of the company's outstanding reputation for developing educational products that support the emotional and behavioral health of individuals with autism and their families," said Ms. Sanver. "We wanted a socially conscious company to take over the site to ensure that it would have a good home and a successful future."

Danya recently unveiled AutismVision: Creating Classroom Connections, a series of video presentations and school curriculums to help educate the classmates of children and teens with autism and
'/>"/>

SOURCE Danya International
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine news :

1. International Eye Foundation Announces Partnership with Newport Creative Communications
2. Ochsner Health System Partners with DocuSys for Presurgical Care, AIMS and Medication Management Technology
3. WeissComm Partners Promotes Diane Weiser to President and Chief Operating Officer
4. Kagome Partners With Raise the Hope to Fight Heart Disease
5. HealthMEDX Partners With Silverchair Learning Systems
6. Turner Investment Partners Added to AHA Diversified Equity Fund
7. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
8. ACM Partners With Tufts Associated Health Plans to Improve the Cost-effective Delivery of Home Infusion Services
9. Medicine Disposal Partnership Will Encourage Public to Flush Less, Crush More
10. Country Music Star Troy Gentry Partners With National Non-Profit Patient Advocate Foundation to Spread the Message About Challenges to Healthcare Access for Insured and Uninsured Americans
11. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Skincare Industry Newcomer Shines 51058 1Skincare Industry Newcomer Shines 51058 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 1For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 3Allied World Schedules Second Quarter 2009 Earnings Announcement and Conference Call 51052 1